Scott Tarriff, CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 43,238 shares at $13.87 ($599K) on 2023-11-02, disclosed to the SEC on 2023-11-03.
Scheduled sale ($599k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.82 | 10,925 | $151K | 25.2% |
| 2 | $13.82 | 10,925 | $151K | 25.2% |
| 3 | $13.87 | 10,694 | $148K | 24.8% |
| 4 | $13.87 | 10,694 | $148K | 24.8% |
| Total | $13.84 avg | 43,238 | $599K | 100% |
| Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |
| EGRX | SELL | 2019-03-04 | $1.9M | — | Filing → |